1. Attili AF, Capocaccia R, Carulli N, Festi D, Roda E, Barbara L, et al. Factors associated with gallstone disease in the MICOL experience. Multicenter Italian Study on Epidemiology of Cholelithiasis. Hepatology 1997;26:809-818. PMID:
9328297.
2. Portincasa P, Moschetta A, Palasciano G. Cholesterol gallstone disease. Lancet 2006;368:230-239. PMID:
16844493.
3. Everhart JE, Ruhl CE. Burden of digestive diseases in the United States part I: overall and upper gastrointestinal diseases. Gastroenterology 2009;136:376-386. PMID:
19124023.
5. Diehl AK. Epidemiology and natural history of gallstone disease. Gastroenterol Clin North Am 1991;20:1-19. PMID:
2022415.
6. Sherlock S, Dooley J. Gallstones and inflammatory gallbladder diseases. In: Sherlock S, Dooley J, editors. Diseases of the liver and biliary system. 11th ed. Oxford: Blackwell Science; 2002. p. 597-628.
7. Trotman BW, Ostrow JD, Soloway RD. Pigment vs cholesterol cholelithiasis: comparison of stone and bile composition. Am J Dig Dis 1974;19:585-590. PMID:
4835328.
8. Attili AF, Carulli N, Roda E, Barbara B, Capocaccia L, Menotti A, et al. Epidemiology of gallstone disease in Italy: prevalence data of the Multicenter Italian Study on Cholelithiasis (M.I.COL.). Am J Epidemiol 1995;141:158-165. PMID:
7817971.
9. Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st century? Curr Gastroenterol Rep 2005;7:132-140. PMID:
15802102.
10. Portincasa P, Wang DQ. Intestinal absorption, hepatic synthesis, and biliary secretion of cholesterol: where are we for cholesterol gallstone formation? Hepatology 2012;55:1313-1316. PMID:
22271308.
11. Sarin SK, Negi VS, Dewan R, Sasan S, Saraya A. High familial prevalence of gallstones in the first-degree relatives of gallstone patients. Hepatology 1995;22:138-141. PMID:
7601405.
12. Katsika D, Grjibovski A, Einarsson C, Lammert F, Lichtenstein P, Marschall HU. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology 2005;41:1138-1143. PMID:
15747383.
13. Wang DQ, Cohen DE, Carey MC. Biliary lipids and cholesterol gallstone disease. J Lipid Res 2009;50(Suppl):S406-S411. PMID:
19017613.
15. Stender S, Nordestgaard BG, Tybjaerg-Hansen A. Elevated body mass index as a causal risk factor for symptomatic gallstone disease: a Mendelian randomization study. Hepatology 2013;58:2133-2141. PMID:
23775818.
16. Banim PJ, Luben RN, Bulluck H, Sharp SJ, Wareham NJ, Khaw KT, et al. The aetiology of symptomatic gallstones quantification of the effects of obesity, alcohol and serum lipids on risk. Epidemiological and biomarker data from a UK prospective cohort study (EPIC-Norfolk). Eur J Gastroenterol Hepatol 2011;23:733-740. PMID:
21623190.
17. Di Ciaula A, Wang DQ, Portincasa P. Gallbladder and gastric motility in obese newborns, pre-adolescents and adults. J Gastroenterol Hepatol 2012;27:1298-1305. PMID:
22497555.
18. Di Ciaula A, Portincasa P. Fat, epigenome and pancreatic diseases: interplay and common pathways from a toxic and obesogenic environment. Eur J Intern Med 2014;25:865-873. PMID:
25457435.
19. Leitzmann MF, Giovannucci EL, Rimm EB, Stampfer MJ, Spiegelman D, Wing AL, et al. The relation of physical activity to risk for symptomatic gallstone disease in men. Ann Intern Med 1998;128:417-425. PMID:
9499324.
20. World Health Organization. Global recommendations on physical activity for health. Geneva: World Health Organization; 2010.
21. Banim PJ, Luben RN, Wareham NJ, Sharp SJ, Khaw KT, Hart AR. Physical activity reduces the risk of symptomatic gallstones: a prospective cohort study. Eur J Gastroenterol Hepatol 2010;22:983-988. PMID:
20130468.
22. Chait A, Bierman EL, Albers JJ. Low-density lipoprotein receptor activity in cultured human skin fibroblasts: mechanism of insulin-induced stimulation. J Clin Invest 1979;64:1309-1319. PMID:
227931.
23. Nepokroeff CM, Lakshmanan MR, Ness GC, Dugan RE, Porter JW. Regulation of the diurnal rhythm of rat liver beta-hydroxy-beta-methylglutaryl coenzmye A reductase activity by insulin, glucagon, cyclic AMP and hydrocortisone. Arch Biochem Biophys 1974;160:387-396. PMID:
4364764.
24. Subbiah MT, Yunker RL. Cholesterol 7 alpha-hydroxylase of rat liver: an insulin sensitive enzyme. Biochem Biophys Res Commun 1984;124:896-902. PMID:
6391484.
25. Kirwan JP, Kohrt WM, Wojta DM, Bourey RE, Holloszy JO. Endurance exercise training reduces glucose-stimulated insulin levels in 60- to 70-year-old men and women. J Gerontol 1993;48:M84-M90. PMID:
8482816.
26. Seals DR, Hagberg JM, Hurley BF, Ehsani AA, Holloszy JO. Effects of endurance training on glucose tolerance and plasma lipid levels in older men and women. JAMA 1984;252:645-649. PMID:
6376837.
27. Tran ZV, Weltman A, Glass GV, Mood DP. The effects of exercise on blood lipids and lipoproteins: a meta-analysis of studies. Med Sci Sports Exerc 1983;15:393-402. PMID:
6645868.
28. Mingrone G, Greco AV, Finotti E, Passi S. Free fatty acids: a stimulus for mucin hypersecretion in cholesterol gallstone biles. Biochim Biophys Acta 1988;958:52-59. PMID:
3334867.
29. Leon AS, Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc 2001;33(6 Suppl):S502-S515. PMID:
11427777.
30. Halloran LG, Schwartz CC, Vlahcevic ZR, Nisman RM, Swell L. Evidence for high-density lipoprotein-free cholesterol as the primary precursor for bile-acid synthesis in man. Surgery 1978;84:1-7. PMID:
208187.
31. Petitti DB, Friedman GD, Klatsky AL. Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol. N Engl J Med 1981;304:1396-1398. PMID:
7231462.
32. Philipp E, Wilckens T, Friess E, Platte P, Pirke KM. Cholecystokinin, gastrin and stress hormone responses in marathon runners. Peptides 1992;13:125-128. PMID:
1320260.
33. Tsunoda K, Shirai Y, Hatakeyama K. Prevalence of cholesterol gallstones positively correlates with per capita daily calorie intake. Hepatogastroenterology 2004;51:1271-1274. PMID:
15362730.
34. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Fruit and vegetable consumption and risk of cholecystectomy in women. Am J Med 2006;119:760-767. PMID:
16945611.
35. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. The effect of long-term intake of cis unsaturated fats on the risk for gallstone disease in men: a prospective cohort study. Ann Intern Med 2004;141:514-522. PMID:
15466768.
36. Leitzmann MF, Stampfer MJ, Willett WC, Spiegelman D, Colditz GA, Giovannucci EL. Coffee intake is associated with lower risk of symptomatic gallstone disease in women. Gastroenterology 2002;123:1823-1830. PMID:
12454839.
37. Ruhl CE, Everhart JE. Association of coffee consumption with gallbladder disease. Am J Epidemiol 2000;152:1034-1038. PMID:
11117612.
38. Walcher T, Haenle MM, Mason RA, Koenig W, Imhof A, Kratzer W, et al. The effect of alcohol, tobacco and caffeine consumption and vegetarian diet on gallstone prevalence. Eur J Gastroenterol Hepatol 2010;22:1345-1351. PMID:
20802339.
39. Kratzer W, Mason RA, Kachele V. Prevalence of gallstones in sonographic surveys worldwide. J Clin Ultrasound 1999;27:1-7. PMID:
9888092.
40. Ginter E. Chenodeoxycholic acid, gallstones and vitamin C. N Engl J Med 1976;295:1260-1261. PMID:
980043.
41. Simon JA, Hudes ES. Serum ascorbic acid and gallbladder disease prevalence among US adults: the Third National Health and Nutrition Examination Survey (NHANES III). Arch Intern Med 2000;160:931-936. PMID:
10761957.
42. Gustafsson U, Wang FH, Axelson M, Kallner A, Sahlin S, Einarsson K. The effect of vitamin C in high doses on plasma and biliary lipid composition in patients with cholesterol gallstones: prolongation of the nucleation time. Eur J Clin Invest 1997;27:387-391. PMID:
9179545.
44. Portincasa P, Di Ciaula A, Palmieri V, Vendemiale G, Altomare E, Palasciano G. Sonographic evaluation of gallstone burden in humans. Ital J Gastroenterol 1994;26:141-144. PMID:
8061341.
45. Barakos JA, Ralls PW, Lapin SA, Johnson MB, Radin DR, Colletti PM, et al. Cholelithiasis: evaluation with CT. Radiology 1987;162:415-418. PMID:
3797654.
46. Pereira SP, Veysey MJ, Kennedy C, Hussaini SH, Murphy GM, Dowling RH. Gallstone dissolution with oral bile acid therapy: importance of pretreatment CT scanning and reasons for nonresponse. Dig Dis Sci 1997;42:1775-1782. PMID:
9286247.
47. Ledro-Cano D. Suspected choledocholithiasis: endoscopic ultrasound or magnetic resonance cholangio-pancreatography?: a systematic review. Eur J Gastroenterol Hepatol 2007;19:1007-1011. PMID:
18049172.
48. Mendez-Sanchez N, Gonzalez V, Aguayo P, Sanchez JM, Tanimoto MA, Elizondo J, et al. Fish oil (n-3) polyunsaturated fatty acids beneficially affect biliary cholesterol nucleation time in obese women losing weight. J Nutr 2001;131:2300-2303. PMID:
11533270.
49. Portincasa P, Ciaula AD, Bonfrate L, Wang DQ. Therapy of gallstone disease: what it was, what it is, what it will be. World J Gastrointest Pharmacol Ther 2012;3:7-20. PMID:
22577615.
50. Wang HH, Portincasa P, de Bari O, Liu KJ, Garruti G, Neuschwander-Tetri BA, et al. Prevention of cholesterol gallstones by inhibiting hepatic biosynthesis and intestinal absorption of cholesterol. Eur J Clin Invest 2013;43:413-426. PMID:
23419155.
51. Broomfield PH, Chopra R, Sheinbaum RC, Bonorris GG, Silverman A, Schoenfield LJ, et al. Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight. N Engl J Med 1988;319:1567-1572. PMID:
3200265.
52. Weinsier RL, Wilson LJ, Lee J. Medically safe rate of weight loss for the treatment of obesity: a guideline based on risk of gallstone formation. Am J Med 1995;98:115-117. PMID:
7847427.
53. Johansson K, Sundstrom J, Marcus C, Hemmingsson E, Neovius M. Risk of symptomatic gallstones and cholecystectomy after a very-low-calorie diet or low-calorie diet in a commercial weight loss program: 1-year matched cohort study. Int J Obes (Lond) 2014;38:279-284. PMID:
23736359.
54. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467-484. PMID:
14530719.
55. Tsai CJ, Leitzmann MF, Willett WC, Giovannucci EL. Weight cycling and risk of gallstone disease in men. Arch Intern Med 2006;166:2369-2374. PMID:
17130391.
56. Li VK, Pulido N, Fajnwaks P, Szomstein S, Rosenthal R, Martinez-Duartez P. Predictors of gallstone formation after bariatric surgery: a multivariate analysis of risk factors comparing gastric bypass, gastric banding, and sleeve gastrectomy. Surg Endosc 2009;23:1640-1644. PMID:
19057954.
57. Everhart JE. Contributions of obesity and weight loss to gallstone disease. Ann Intern Med 1993;119:1029-1035. PMID:
8214980.
58. Wudel LJ Jr, Wright JK, Debelak JP, Allos TM, Shyr Y, Chapman WC. Prevention of gallstone formation in morbidly obese patients undergoing rapid weight loss: results of a randomized controlled pilot study. J Surg Res 2002;102:50-56. PMID:
11792152.
59. Uy MC, Talingdan-Te MC, Espinosa WZ, Daez ML, Ong JP. Ursodeoxycholic acid in the prevention of gallstone formation after bariatric surgery: a meta-analysis. Obes Surg 2008;18:1532-1538. PMID:
18574646.
60. Sugerman HJ, Brewer WH, Shiffman ML, Brolin RE, Fobi MA, Linner JH, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 1995;169:91-96. PMID:
7818005.
61. Booker ML, Scott TE, La Morte WW. Effects of dietary fish oil on biliary phospholipids and prostaglandin synthesis in the cholesterol-fed prairie dog. Lipids 1990;25:27-32. PMID:
2325507.
62. Mizuguchi K, Yano T, Kawano H, Abei M, Tanaka N. Preventive effects of eicosapentaenoic acid (EPA) on cholesterol gallstone formation in hamsters. Nihon Yakurigaku Zasshi 1997;110(Suppl 1):50P-55P.
63. Smit MJ, Temmerman AM, Wolters H, Kuipers F, Beynen AC, Vonk RJ. Dietary fish oil-induced changes in intrahepatic cholesterol transport and bile acid synthesis in rats. J Clin Invest 1991;88:943-951. PMID:
1885779.
64. Tarantino I, Warschkow R, Steffen T, Bisang P, Schultes B, Thurnheer M. Is routine cholecystectomy justified in severely obese patients undergoing a laparoscopic Roux-en-Y gastric bypass procedure?: a comparative cohort study. Obes Surg 2011;21:1870-1878. PMID:
21863228.
65. Worni M, Guller U, Shah A, Gandhi M, Shah J, Rajgor D, et al. Cholecystectomy concomitant with laparoscopic gastric bypass: a trend analysis of the nationwide inpatient sample from 2001 to 2008. Obes Surg 2012;22:220-229. PMID:
22183984.
66. Moschetta A, Stolk MF, Rehfeld JF, Portincasa P, Slee PH, Koppeschaar HP, et al. Severe impairment of postprandial cholecystokinin release and gall-bladder emptying and high risk of gallstone formation in acromegalic patients during Sandostatin LAR. Aliment Pharmacol Ther 2001;15:181-185. PMID:
11148435.
67. Montini M, Gianola D, Pagani MD, Pedroncelli A, Caldara R, Gherardi F, et al. Cholelithiasis and acromegaly: therapeutic strategies. Clin Endocrinol (Oxf) 1994;40:401-406. PMID:
8187305.
68. Avila NA, Shawker TH, Roach P, Bradford MH, Skarulis MC, Eastman R. Sonography of gallbladder abnormalities in acromegaly patients following octreotide and ursodiol therapy: incidence and time course. J Clin Ultrasound 1998;26:289-294. PMID:
9641388.
69. Venneman NG, Besselink MG, Keulemans YC, Vanberge-Henegouwen GP, Boermeester MA, Broeders IA, et al. Ursodeoxycholic acid exerts no beneficial effect in patients with symptomatic gallstones awaiting cholecystectomy. Hepatology 2006;43:1276-1283. PMID:
16729326.
70. Maringhini A, Ciambra M, Baccelliere P, Raimondo M, Orlando A, Tine F, et al. Biliary sludge and gallstones in pregnancy: incidence, risk factors, and natural history. Ann Intern Med 1993;119:116-120. PMID:
8512160.
71. Marks JW, Stein T, Schoenfield LJ. Natural history and treatment with ursodiol of gallstones formed during rapid loss of weight in man. Dig Dis Sci 1994;39:1981-1984. PMID:
8082507.
72. Marjoribanks J, Farquhar C, Roberts H, Lethaby A. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2012;(7):CD004143PMID:
22786488.
73. Cirillo DJ, Wallace RB, Rodabough RJ, Greenland P, LaCroix AZ, Limacher MC, et al. Effect of estrogen therapy on gallbladder disease. JAMA 2005;293:330-339. PMID:
15657326.
74. Rubin RA, Kowalski TE, Khandelwal M, Malet PF. Ursodiol for hepatobiliary disorders. Ann Intern Med 1994;121:207-218. PMID:
8017748.
75. Villanova N, Bazzoli F, Taroni F, Frabboni R, Mazzella G, Festi D, et al. Gallstone recurrence after successful oral bile acid treatment: a 12-year follow-up study and evaluation of long-term postdissolution treatment. Gastroenterology 1989;97:726-731. PMID:
2753332.
76. Petroni ML, Jazrawi RP, Pazzi P, Zuin M, Lanzini A, Fracchia M, et al. Risk factors for the development of gallstone recurrence following medical dissolution. The British-Italian Gallstone Study Group. Eur J Gastroenterol Hepatol 2000;12:695-700. PMID:
10912491.
77. Rabenstein T, Radespiel-Troger M, Hopfner L, Benninger J, Farnbacher M, Greess H, et al. Ten years experience with piezoelectric extracorporeal shockwave lithotripsy of gallbladder stones. Eur J Gastroenterol Hepatol 2005;17:629-639. PMID:
15879725.
79. Marschall HU, Einarsson C. Gallstone disease. J Intern Med 2007;261:529-542. PMID:
17547709.